REG - Alliance Pharma PLCAviva PLC - Major Interest in Shares <ALAPH.L><AV.L>
.
For best results when printing this announcement, please click on the link below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20100709:nRSI1481Pa
RNS Number : 1481P
Alliance Pharma PLC
09 July 2010
For immediate release 9 July 2010
Alliance Pharma plc
TR-1: Notification of major interests in shares
1. Identity of the issuer or the underlying issuer
Alliance Pharma plc
of existing shares to which voting rights are
attached:
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already
issued to which voting rights are attached.
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
Aviva plc & its subsidiaries
notification obligation:
4. Full name of shareholder(s)
Registered Holder:
(if different from 3.):
BNY Norwich Union Nominees Limited
696,772*
Chase (GA Grou) Nominees Limited
4,662,107*
CUIM Nominee Limited
2,770,404*
*denotes direct interest
BNP Paribas - London
2,237,424
Chase Nominees Limited
7,406,778
State Street Nominees Limited
5. Date of the transaction and date on
07 July 2010
which the threshold is crossed or
reached:
6. Date on which issuer notified:
09 July 2010
7. Threshold(s) that is/are crossed or
<3% to 3% Change at Direct Interest Level
reached:
8. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous
Resulting situation after the triggering transaction
shares to the triggering
if possible using transaction
the ISIN CODE
Number Number
Number Number of voting % of voting rights
of of
of shares rights
Shares Voting
Rights
Direct Indirect
Direct Indirect
Ordinary Shares 19,196,755
19,196,755 19,516,755 8,129,283
11,387,472 3.50% 4.89%
GB0031030819
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration
Exercise/ Number of voting % of voting
instrument date
Conversion Period rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Exercise price
Expiration date Exercise/ Number of voting rights instrument refers
to % of voting rights
instrument
Conversion period
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
19,516,755 8.39%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of
controlled undertakings:- Aviva Investors Global
Services Limited:# Aviva plc (Parent Company)# Aviva Group Holdings Limited (wholly owned
subsidiary of Aviva plc)# Aviva Investors Holdings
Limited (wholly owned subsidiary of Aviva Group Holdings Limited)# Aviva Investors Global Services Limited
(wholly owned subsidiary of Aviva Investors Holdings
Limited)
Proxy Voting:
10. Name of the proxy holder:
See Section 4
11. Number of voting rights proxy holder will cease
N/A
to hold:
12. Date on which proxy holder will cease to hold
N/A
voting rights:
13. Additional information:
Figures are based on the total number of voting rights of
232,519,622.
14. Contact name:
Neil Whittaker
15. Contact telephone number:
01603 684420
This information is provided by RNS
The company news service from the London Stock Exchange
